Establishment of humanised xenograft models as in vivo study for lung metastasis of osteosarcoma

  • 0Department of Biochemistry and Molecular Medicine, Universiti Teknologi MARA, Sungai Buloh, 47000 Selangor, Malaysia.

|

|

Summary

This summary is machine-generated.

Researchers developed a new osteosarcoma (OS) mouse model to study metastasis. This model, using human cancer cells in mice, successfully showed tumor development and lung metastasis, aiding preclinical cancer research.

Area Of Science

  • Oncology
  • Preclinical Cancer Research
  • Animal Models

Background

  • Humanised xenograft models are crucial for preclinical cancer research, aiding drug evaluation and targeted therapy.
  • Osteosarcoma (OS) metastasis significantly impacts patient prognosis and treatment, yet understanding its mechanisms is hindered by a lack of appropriate animal models.
  • Developing a reliable OS lung metastasis model is essential for advancing basic research and therapeutic strategies.

Purpose Of The Study

  • To establish a functional mouse model for studying osteosarcoma (OS) lung metastasis.
  • To investigate the biological mechanisms underlying OS metastasis progression.
  • To provide a platform for preclinical evaluation of novel OS therapies.

Main Methods

  • Established a tumour-bearing mouse model by injecting the HOS-143B cell line into male NOD.SCID gamma (NSG) mice.
  • Administered cancer cells intramuscularly (hind leg) and subcutaneously (back).
  • Monitored primary and metastatic tumour growth using palpation and digital callipers; confirmed metastasis via H&E staining.

Main Results

  • Mice injected with 1 million cancer cells did not develop tumours.
  • Mice injected with three million cancer cells exhibited tumour development and lung metastasis within 25 days.
  • Histopathological analysis confirmed the presence of metastasis in the lung tissue.

Conclusions

  • Successfully established a lung metastatic osteosarcoma (OS) mouse model.
  • This model is valuable for biological studies of OS metastasis.
  • The model is essential for safety and efficacy testing prior to clinical trials, accelerating therapeutic translation.